A Study to Evaluate How Mirabegron Enters and Leaves the Bloodstream According to Age and Sex

NCT01285596 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
75
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Astellas Pharma Inc